An article for patients, GPs, and non-specialist healthcare professionals
Allergic bronchopulmonary aspergillosis (ABPA) is often discussed in terms of lung function, immunology, and imaging. Far less often do we talk about its impact on everyday life, particularly on a person’s ability to work.
A poll run within the National Aspergillosis Centre patient community asked a simple but powerful question:
Who is still able to work while living with ABPA – and who has had to stop or retire?
The responses provide an important insight into the functional and socioeconomic burden of ABPA.
Key findings from the poll (patient-reported)
-
Working full time: 17%
-
Working part time (days or hours): 18% combined
-
Not working: 30%
-
Retirement age: 21%
-
Retired early for health reasons: 12%
-
Currently on sick leave / full-time carer / pre-diagnosis: small but notable groups
Even allowing for the informal nature of a social media poll, the overall pattern is clear.
What this tells us
1. Sustained full-time work is uncommon in ABPA
Fewer than one in five respondents were able to work full time. Even among those still working, many described reduced hours, flexible arrangements, or fragile employment dependent on day-to-day health.
ABPA is often incompatible with predictable, high-demand working patterns.
2. ABPA frequently leads to work loss or early retirement
A substantial proportion of respondents were either:
-
No longer working at all, or
-
Retired earlier than planned specifically because of health
This is particularly striking given that ABPA often affects people during their working years and may coexist with asthma, bronchiectasis, or long-term steroid use.
3. “Retirement age” can hide health-forced exit
Some respondents selected “retirement age,” but accompanying comments revealed that many:
-
Left work earlier than expected
-
Changed careers or reduced responsibilities years before retirement
-
Worked through ill health until they no longer could
This matters when interpreting employment statistics: health-driven work loss may be underestimated.
4. Unpaid work and instability are often overlooked
The poll also highlighted:
-
People currently on prolonged sick leave
-
Full-time unpaid carers
-
Individuals still awaiting diagnosis but already struggling to work
These groups are frequently invisible in employment data, yet represent significant personal and societal impact.
Why ABPA affects the ability to work
For patients and non-specialists, it is important to understand that work difficulties in ABPA are not simply due to “asthma symptoms.”
Common contributors include:
-
Chronic breathlessness and cough
-
Severe fatigue and post-exertional exhaustion
-
Recurrent chest infections
-
Steroid side-effects (muscle weakness, bone disease, mood changes, diabetes risk)
-
Unpredictable flare-ups requiring rest, antibiotics, or hospital care
-
Cognitive and emotional burden of long-term illness
Together, these make consistent attendance, physical work, and high cognitive load difficult to sustain.
Implications for patients
-
Difficulty working is not a personal failure
-
Many others with ABPA face similar challenges
-
Adjustments, reduced hours, or stopping work altogether may be medically appropriate
-
Asking for support is reasonable and justified
Implications for GPs and non-specialist clinicians
-
Employment status should be considered a key outcome of disease control
-
Fit notes, occupational health input, and benefits documentation are part of holistic care
-
ABPA is a fluctuating condition – patients may cope for periods and then deteriorate
-
Statements such as “lung function is stable” do not always reflect real-world functioning
Understanding the work impact helps clinicians better support patients in consultations, reports, and advocacy.
Implications for systems and policy
This poll reinforces that ABPA carries a significant socioeconomic burden, including:
-
Reduced workforce participation
-
Early retirement
-
Increased reliance on health and social support systems
Any assessment of disability, employment capability, or long-term planning must take into account:
-
Variability over time
-
Treatment burden
-
Side-effects of necessary medications
In summary
This patient poll sends a consistent message:
ABPA commonly limits the ability to work, often leading to reduced hours, unstable employment, or early exit from the workforce.
For patients, this experience is shared and valid.
For clinicians, it is a reminder that ABPA is not just a radiological or immunological diagnosis, but a life-limiting condition with real-world consequences.
Share this post
Latest News posts
COVID Vaccination Side Effects
April 26, 2021
How to manage breathlessness
April 23, 2021
Indoor Air Quality at Home (NHS guidelines )
April 12, 2021
Aspergillosis monthly patient & carer meeting
April 7, 2021
COVID Vaccination – hesitating?
February 24, 2021
What is an MDT?
February 17, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
